Community Healthcare Trust (CHCT)
(Delayed Data from NYSE)
$16.42 USD
-0.40 (-2.38%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $16.46 +0.04 (0.24%) 7:58 PM ET
4-Sell of 5 4
C Value D Growth A Momentum C VGM
Income Statements
Fiscal Year end for Community Healthcare Trust Incorporated falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 113 | 98 | 91 | 76 | 61 |
Cost Of Goods | 21 | 17 | 15 | 14 | 12 |
Gross Profit | 92 | 81 | 75 | 62 | 49 |
Selling & Adminstrative & Depr. & Amort Expenses | 67 | 47 | 43 | 34 | 30 |
Income After Depreciation & Amortization | 25 | 34 | 33 | 28 | 19 |
Non-Operating Income | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 18 | 12 | 11 | 9 | 9 |
Pretax Income | 8 | 22 | 23 | 19 | 10 |
Income Taxes | 0 | 0 | 0 | 0 | 1 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 8 | 22 | 22 | 19 | 8 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 8 | 22 | 22 | 19 | 8 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 77 | 67 | 64 | 53 | 41 |
Depreciation & Amortization (Cash Flow) | 52 | 33 | 31 | 26 | 23 |
Income After Depreciation & Amortization | 25 | 34 | 33 | 28 | 19 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 25.20 | 23.63 | 23.26 | 21.58 | 18.69 |
Diluted EPS Before Non-Recurring Items | 0.20 | 0.81 | 0.87 | 0.80 | 0.37 |
Diluted Net EPS (GAAP) | 0.20 | 0.81 | 0.87 | 0.80 | 0.37 |
Fiscal Year end for Community Healthcare Trust Incorporated falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 27.52 | 29.33 | 29.12 | 28.74 | 27.81 |
Cost Of Goods | 5.57 | 5.79 | 5.60 | 5.46 | 4.79 |
Gross Profit | 21.94 | 23.54 | 23.53 | 23.28 | 23.02 |
SG&A, R&D, and Dept/Amort Expenses | 15.55 | 14.81 | 13.98 | 14.83 | 13.01 |
Income After SG&A, R&D, and Dept/Amort Expenses | 6.39 | 8.73 | 9.55 | 8.45 | 10.01 |
Non-Operating Income | -10.83 | 0.00 | 0.04 | -0.32 | 0.70 |
Interest Expense | 5.99 | 5.06 | 5.02 | 4.64 | 4.14 |
Pretax Income | -10.43 | 3.67 | 4.57 | 3.49 | 6.58 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -10.43 | 3.67 | 4.57 | 3.49 | 6.58 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -10.43 | 3.67 | 4.57 | 3.49 | 6.58 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 26.48 | 26.30 | 25.98 | 25.51 | 25.07 |
Diluted EPS Before Non-Recurring Items | -0.42 | 0.11 | 0.18 | 0.11 | 0.24 |
Diluted Net EPS (GAAP) | -0.42 | 0.11 | 0.17 | 0.11 | 0.24 |